29.04.2024
. Significant progress was made during the COVID-19 pandemic due to the dynamic development of vaccine research
29.02.2024
The pandemic of coronavirus disease 2019 (COVID-19), etiologically related to the SARS-CoV-2 virus
27.10.2023
and fibrosis in immunemediated rheumatic diseases (IMRD), malignant neoplasms, atherosclerosis, COVID
31.08.2023
During the three years that have passed since the beginning of the COVID-19 pandemic, many new
28.06.2023
in the context of the COVID-19 pandemic, such switching occurred for non-medical reasons as well. However
01.03.2023
the development of the COVID-19 pandemic, which has become a challenge to all mankind, a large number of new
17.01.2023
structures associated with COVID-19. A literature review has been carried out with the use of the medical
30.11.2022
During the pandemic COVID-19, there has been an increase in the number of patients with non
01.07.2022
14.05.2022
Interleukin 18 in Immune-mediated rheumatic diseases and COVID-19
13.05.2022
of IMIDs and also in the hyper-response phase of COVID-19 are reviewed.
01.03.2022
, and safety during the COVID-19 pandemic.
27.02.2022
The problem of coronavirus disease 2019 (Coronavirus diseases, COVID-19) two years later still
27.12.2021
and musculoskeletal diseases (RMD) and medical workers at the beginning of the COVID-19.
Material and methods. 150
26.12.2021
and pharmacotherapy of ASD and coronavirus disease 2019 (COVID-19) are considered.
26.12.2021
The materials of the Russian NIIR/ARP-COVID-19 database, which included adult (over 18 years old
05.09.2021
infections, an increase in the risk of a severe course of COVID-19 (coronavirus disease 2019), a decrease
03.08.2021
infections, an increase in the risk of a severe course of COVID-19 (coronavirus disease 2019), a decrease
13.07.2021
the coronavirus disease (COVID-19) pandemic, affected more than 157 million people in all regions of the world
13.07.2021
Combating the consequences of COVID-19, a disease caused by the new coronavirus infection SARS-CoV
